Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of natalizumab in persons with multiple sclerosis: 2022 update.
Morrow SA, Clift F, Devonshire V, Lapointe E, Schneider R, Stefanelli M, Vosoughi R. Morrow SA, et al. Among authors: schneider r. Mult Scler Relat Disord. 2022 Sep;65:103995. doi: 10.1016/j.msard.2022.103995. Epub 2022 Jun 26. Mult Scler Relat Disord. 2022. PMID: 35810718 Free article. Review.
CD20+ T cells in multiple sclerosis.
Schneider R. Schneider R. Mult Scler Relat Disord. 2015 Jan;4(1):58-9. doi: 10.1016/j.msard.2014.09.213. Epub 2014 Oct 7. Mult Scler Relat Disord. 2015. PMID: 25787054 No abstract available.
Vitamin D as disease-modifying therapy for multiple sclerosis?
Lincoln MR, Schneider R, Oh J. Lincoln MR, et al. Among authors: schneider r. Expert Rev Clin Immunol. 2021 Jul;17(7):691-693. doi: 10.1080/1744666X.2021.1915772. Epub 2021 Apr 15. Expert Rev Clin Immunol. 2021. PMID: 33836645 No abstract available.
Bruton's Tyrosine Kinase Inhibition in Multiple Sclerosis.
Schneider R, Oh J. Schneider R, et al. Curr Neurol Neurosci Rep. 2022 Nov;22(11):721-734. doi: 10.1007/s11910-022-01229-z. Epub 2022 Oct 27. Curr Neurol Neurosci Rep. 2022. PMID: 36301434 Free PMC article. Review.
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J. Kalia LV, et al. Among authors: schneider r. Nat Rev Neurol. 2024 Oct 7. doi: 10.1038/s41582-024-01023-0. Online ahead of print. Nat Rev Neurol. 2024. PMID: 39375563 Review.
3,949 results